Literature DB >> 27606440

Applications of CRISPR technologies in research and beyond.

Rodolphe Barrangou1, Jennifer A Doudna2,3,4.   

Abstract

Programmable DNA cleavage using CRISPR-Cas9 enables efficient, site-specific genome engineering in single cells and whole organisms. In the research arena, versatile CRISPR-enabled genome editing has been used in various ways, such as controlling transcription, modifying epigenomes, conducting genome-wide screens and imaging chromosomes. CRISPR systems are already being used to alleviate genetic disorders in animals and are likely to be employed soon in the clinic to treat human diseases of the eye and blood. Two clinical trials using CRISPR-Cas9 for targeted cancer therapies have been approved in China and the United States. Beyond biomedical applications, these tools are now being used to expedite crop and livestock breeding, engineer new antimicrobials and control disease-carrying insects with gene drives.

Entities:  

Year:  2016        PMID: 27606440     DOI: 10.1038/nbt.3659

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  204 in total

Review 1.  CRISPR-Based Technologies and the Future of Food Science.

Authors:  Kurt Selle; Rodolphe Barrangou
Journal:  J Food Sci       Date:  2015-10-07       Impact factor: 3.167

2.  Unraveling the potential of CRISPR-Cas9 for gene therapy.

Authors:  Rodolphe Barrangou; Andrew P May
Journal:  Expert Opin Biol Ther       Date:  2014-12-23       Impact factor: 4.388

3.  Rational design of a split-Cas9 enzyme complex.

Authors:  Addison V Wright; Samuel H Sternberg; David W Taylor; Brett T Staahl; Jorge A Bardales; Jack E Kornfeld; Jennifer A Doudna
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

4.  RNA-mediated programmable DNA cleavage.

Authors:  Rodolphe Barrangou
Journal:  Nat Biotechnol       Date:  2012-09       Impact factor: 54.908

5.  Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.

Authors:  Ayal Hendel; Rasmus O Bak; Joseph T Clark; Andrew B Kennedy; Daniel E Ryan; Subhadeep Roy; Israel Steinfeld; Benjamin D Lunstad; Robert J Kaiser; Alec B Wilkens; Rosa Bacchetta; Anya Tsalenko; Douglas Dellinger; Laurakay Bruhn; Matthew H Porteus
Journal:  Nat Biotechnol       Date:  2015-06-29       Impact factor: 54.908

6.  Phage response to CRISPR-encoded resistance in Streptococcus thermophilus.

Authors:  Hélène Deveau; Rodolphe Barrangou; Josiane E Garneau; Jessica Labonté; Christophe Fremaux; Patrick Boyaval; Dennis A Romero; Philippe Horvath; Sylvain Moineau
Journal:  J Bacteriol       Date:  2007-12-07       Impact factor: 3.490

7.  Naïve Induced Pluripotent Stem Cells Generated From β-Thalassemia Fibroblasts Allow Efficient Gene Correction With CRISPR/Cas9.

Authors:  Yuanyuan Yang; Xiaobai Zhang; Li Yi; Zhenzhen Hou; Jiayu Chen; Xiaochen Kou; Yanhong Zhao; Hong Wang; Xiao-Fang Sun; Cizhong Jiang; Yixuan Wang; Shaorong Gao
Journal:  Stem Cells Transl Med       Date:  2015-12-16       Impact factor: 6.940

8.  CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes.

Authors:  Puping Liang; Yanwen Xu; Xiya Zhang; Chenhui Ding; Rui Huang; Zhen Zhang; Jie Lv; Xiaowei Xie; Yuxi Chen; Yujing Li; Ying Sun; Yaofu Bai; Zhou Songyang; Wenbin Ma; Canquan Zhou; Junjiu Huang
Journal:  Protein Cell       Date:  2015-04-18       Impact factor: 14.870

9.  Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

Authors:  David Bikard; Chad W Euler; Wenyan Jiang; Philip M Nussenzweig; Gregory W Goldberg; Xavier Duportet; Vincent A Fischetti; Luciano A Marraffini
Journal:  Nat Biotechnol       Date:  2014-10-05       Impact factor: 54.908

10.  Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac.

Authors:  Fei Xie; Lin Ye; Judy C Chang; Ashley I Beyer; Jiaming Wang; Marcus O Muench; Yuet Wai Kan
Journal:  Genome Res       Date:  2014-08-05       Impact factor: 9.043

View more
  246 in total

1.  The Interfaces of Genetic Conflict Are Hot Spots for Innovation.

Authors:  Joshua Carter; Connor Hoffman; Blake Wiedenheft
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

Review 2.  CRISPR applications in ophthalmologic genome surgery.

Authors:  Thiago Cabral; James E DiCarlo; Sally Justus; Jesse D Sengillo; Yu Xu; Stephen H Tsang
Journal:  Curr Opin Ophthalmol       Date:  2017-05       Impact factor: 3.761

Review 3.  Gene therapy and genome surgery in the retina.

Authors:  James E DiCarlo; Vinit B Mahajan; Stephen H Tsang
Journal:  J Clin Invest       Date:  2018-06-01       Impact factor: 14.808

Review 4.  Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.

Authors:  Ling Li; Shuo Hu; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2018-04-18       Impact factor: 12.479

5.  Mechanisms of improved specificity of engineered Cas9s revealed by single-molecule FRET analysis.

Authors:  Digvijay Singh; Yanbo Wang; John Mallon; Olivia Yang; Jingyi Fei; Anustup Poddar; Damon Ceylan; Scott Bailey; Taekjip Ha
Journal:  Nat Struct Mol Biol       Date:  2018-04-05       Impact factor: 15.369

6.  Inhibition of CRISPR-Cas9 with Bacteriophage Proteins.

Authors:  Benjamin J Rauch; Melanie R Silvis; Judd F Hultquist; Christopher S Waters; Michael J McGregor; Nevan J Krogan; Joseph Bondy-Denomy
Journal:  Cell       Date:  2016-12-29       Impact factor: 41.582

Review 7.  CRISPR-Cas9 Probing of Infectious Diseases and Genetic Disorders.

Authors:  Sivaprakash Ramalingam; Saravanabhavan Thangavel
Journal:  Indian J Pediatr       Date:  2019-07-31       Impact factor: 1.967

8.  Rapid and Scalable Characterization of CRISPR Technologies Using an E. coli Cell-Free Transcription-Translation System.

Authors:  Ryan Marshall; Colin S Maxwell; Scott P Collins; Thomas Jacobsen; Michelle L Luo; Matthew B Begemann; Benjamin N Gray; Emma January; Anna Singer; Yonghua He; Chase L Beisel; Vincent Noireaux
Journal:  Mol Cell       Date:  2018-01-04       Impact factor: 17.970

9.  Spatiotemporal Control of CRISPR/Cas9 Function in Cells and Zebrafish using Light-Activated Guide RNA.

Authors:  Wenyuan Zhou; Wes Brown; Anirban Bardhan; Michael Delaney; Amber S Ilk; Randy R Rauen; Shoeb I Kahn; Michael Tsang; Alexander Deiters
Journal:  Angew Chem Int Ed Engl       Date:  2020-04-06       Impact factor: 15.336

10.  CRISPRi/a Screening with Human iPSCs.

Authors:  Masataka Nishiga; Lei S Qi; Joseph C Wu
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.